Paysign, Inc. (NASDAQ:PAYS) Major Shareholder Topline Capital Partners, Lp Sells 154,982 Shares of Stock

Paysign, Inc. (NASDAQ:PAYS) major shareholder Topline Capital Partners, Lp sold 154,982 shares of the business’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $3.06, for a total value of $474,244.92. Following the sale, the insider now owns 5,456,146 shares of the company’s stock, valued at approximately $16,695,806.76. This represents a 2.76 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Topline Capital Partners, Lp also recently made the following trade(s):

• On Tuesday, December 31st, Topline Capital Partners, Lp sold 20,834 shares of Paysign stock. The shares were sold at an average price of $3.03, for a total transaction of $63,127.02.

Paysign Trading Down 5.5 %

Shares of NASDAQ:PAYS opened at $3.07 on Thursday. The stock has a market cap of $164.40 million, a PE ratio of 20.47 and a beta of 0.95. The stock’s fifty day simple moving average is $3.25 and its two-hundred day simple moving average is $3.94. Paysign, Inc. has a 1-year low of $2.48 and a 1-year high of $5.59.

Paysign (NASDAQ:PAYS) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The company had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. During the same period last year, the firm earned $0.02 earnings per share. On average, sell-side analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Paysign

Several hedge funds have recently modified their holdings of PAYS. JPMorgan Chase & Co. increased its position in shares of Paysign by 164.1% during the third quarter. JPMorgan Chase & Co. now owns 63,247 shares of the company’s stock valued at $232,000 after acquiring an additional 39,299 shares during the last quarter. Sanctuary Advisors LLC increased its position in shares of Paysign by 4.3% during the 3rd quarter. Sanctuary Advisors LLC now owns 121,089 shares of the company’s stock valued at $419,000 after purchasing an additional 5,000 shares during the last quarter. Barclays PLC raised its stake in shares of Paysign by 327.4% during the 3rd quarter. Barclays PLC now owns 47,090 shares of the company’s stock worth $173,000 after purchasing an additional 36,071 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of Paysign by 257.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company’s stock worth $164,000 after buying an additional 32,245 shares during the last quarter. Finally, Bard Associates Inc. bought a new position in Paysign during the third quarter valued at about $103,000. Institutional investors own 25.89% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PAYS. Lake Street Capital initiated coverage on shares of Paysign in a report on Friday, December 20th. They set a “buy” rating and a $6.00 price objective for the company. Barrington Research reiterated an “outperform” rating and set a $7.00 price target on shares of Paysign in a research note on Monday, November 4th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.